Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
ATUM and Phylex BioSciences Collaborate to Accelerate the Development of a Universal SARS Coronavirus Vaccine
Tuesday, June 16, 2020ATUM and Phylex BioSciences have entered into a collaboration to leverage ATUMs LeapIn Transposase platform to develop the cell line essential to the manufacturing of Phylexs universal SARS coronavirus vaccine candidate The Phylex vaccine candidate a...
Magenta Therapeutics and Beam Therapeutics Announce Collaboration to Evaluate Targeted Antibody-Drug Conjugate (ADC) MGTA-117
Monday, June 15, 2020Magenta Therapeutics and Beam Therapeutics announced a nonexclusive research and clinical collaboration agreement to evaluate the potential utility of MGTA Magentas novel targeted ADC for conditioning of patients with sickle cell disease and betathal...
City of Hope signs licensing agreement with Scopus BioPharma Inc. to develop novel, targeted immuno-oncology gene therapy
Saturday, June 13, 2020City of Hope a worldrenowned independent research and treatment center for cancer diabetes and other lifethreatening diseases has signed an exclusive worldwide licensing agreement with Scopus BioPharma Inc a biopharmaceutical company focused on novel...
FDA Approves Merck’s GARDASIL 9 for the Prevention of Certain HPV-Related Head and Neck Cancers
Saturday, June 13, 2020Merck known as MSD outside the United States and Canada today announced that the US Food and Drug Administration FDA has approved an expanded indication for GARDASIL for the prevention of oropharyngeal and other head and neck cancers caused by HPV T...
Sobi and Selecta Announce Strategic Licensing Agreement for SEL-212, a Phase 3-ready Novel Treatment for Chronic Refractory Gout
Friday, June 12, 2020Swedish Orphan Biovitrum AB and Selecta Biosciences Inc Nasdaq SELB announced that the companies have entered into a strategic licensing agreement for the product candidate SEL SEL is a combination of Selectas tolerogenic ImmTOR immune tolerance pla...
Egle Therapeutics Enters Into a Corporate Strategic Research Alliance with Takeda
Friday, June 12, 2020Egle Therapeutics SAS an emerging biotechnology company focused on developing firstinclass immunotherapies targeting immune suppressor regulatory Tcells for oncology and autoimmune diseases announced today a corporate strategic research alliance with...
DelMar to Acquire Adgero Biopharmaceuticals, Expands Late-Stage Oncology Pipeline
Thursday, June 11, 2020DelMar Pharmaceuticals Inc and Adgero Biopharmaceuticals Holdings Inc Adgero today announced the companies have entered into a definitive merger agreement pursuant to which DelMar a biopharmaceutical company focused on the development of new solid tu...
BryoLogyx Announces Agreements with Neurotrope to Acquire Bryostatin-1 Immuno-Oncology Data Package, Supply Synthetic Bryostatin-1
Thursday, June 11, 2020BryoLogyx Incannounced it has entered into two agreements with Neurotrope Inc Nasdaq NTRP to acquire Neurotropes preclinical data package and drug product for use of bryostatin in an immunooncology application and to supply Neurotrope with synthetic...
Evox Therapeutics Announces a Multi-target RNAi and Antisense Research Collaboration and License Agreement With Lilly
Wednesday, June 10, 2020Evox Therapeutics Ltd a leading exosome therapeutics company is pleased to announce a research collaboration and license agreement with Eli Lilly and Company to leverage Evoxs proprietary DeliverEX platform to develop and deliver RNA interference RNA...
Lyvgen Announces Clinical Trial Collaboration With MSD
Wednesday, June 10, 2020Lyvgen a biopharmaceutical company focused on developing innovative immunooncology therapeutics announces that it has entered into a clinical trial collaboration agreement with a subsidiary of Merck Co Inc Kenilworth New Jersey USA known as MSD outs...
